| 期 |
标题 |
文件 |
| 卷 19, 编号 3 (2024) |
A Landscape on Lymphatic Filariasis with its Effects and Recent Advanced Treatments |
(Eng)
|
|
Yadav A., Yadav S., Alam A.
|
| 卷 19, 编号 2 (2024) |
A Rational Approach To Antitubercular Drug Design: Molecular Docking, Prediction of ADME Properties and Evaluation of Antitubercular Activity of Novel Isonicotinamide Scaffold |
(Eng)
|
|
Das P., Gumma S., Nayak A., Menghani S., Mandhadi J., Prabhu P.
|
| 卷 19, 编号 4 (2024) |
Acknowledgements to Reviewers |
(Eng)
|
|
|
| 卷 19, 编号 2 (2024) |
Antimicrobial Stewardship Program: Time to be Focused in Speciality Settings of Leprosy Institute and Related Health Care Setup |
(Eng)
|
|
Thangaraju P., Velmurugan H., Venkatesan S.
|
| 卷 19, 编号 1 (2024) |
Biological Importance and Therapeutic Potential of Calycopterin from Dracocephalum kotschyi: An Overview of Current Scientific Research Work |
(Eng)
|
|
Patel D., Patel K.
|
| 卷 19, 编号 4 (2024) |
Biological Potential and Therapeutic Effectiveness of Artemetin from Traditional to Modern Medicine: An Update on Pharmacological Activities and Analytical Aspects |
(Eng)
|
|
Patel K., Patel D.
|
| 卷 19, 编号 4 (2024) |
Cholecalciferol Exhibits no Antibacterial Effect on Staphylococcus aureus and Escherichia coli: An in vitro Study |
(Eng)
|
|
Kurian S., Biswas A., Kulavalli S., Aranjani J., Pattanaik A., Munisamy M., Saravu K., Rodrigues G., Miraj S.
|
| 卷 19, 编号 1 (2024) |
COVID-19 Study, Diagnostic and Therapeutic Transition |
(Eng)
|
|
Lu D., Lu T.
|
| 卷 19, 编号 3 (2024) |
Current Influenza Antiviral Drug Strategy Limitations and Future Development of both Preventative and Intervention Antiviral Therapies |
(Eng)
|
|
Ahmad F.
|
| 卷 19, 编号 1 (2024) |
Current Prospects in Rheumatoid Arthritis: Pathophysiology, Genetics, and Treatments |
(Eng)
|
|
Khan S., Mohan K., Muzammil S., Alam M., Khayyam K.
|
| 卷 19, 编号 1 (2024) |
Eco-friendly Biosynthesis of Ag-NPs by Streptomyces griseus with Anti-Candida albicans and Antitumor Activity |
(Eng)
|
|
Abou El-Enain I., Abed N., Helal E., Abdelkhalek E., Suleiman W., Safwat N., Yosri M.
|
| 卷 19, 编号 1 (2024) |
Effects of Active Compounds of Nigella sativa in COVID-19: A Narrative Review |
(Eng)
|
|
Usmani H., Malik S., Arya A., Mahto P., Kant R., Dua R., Sindhwani G., Mirza A., Panda P.
|
| 卷 19, 编号 1 (2024) |
Essential Oils as Alternative Antimicrobials: Current Status |
(Eng)
|
|
Sahu A., Parai D., Choudhary H., Singh D.
|
| 卷 19, 编号 4 (2024) |
Expression of mRNA-TLR-5 Gene in Patients with Endometriosis using Real-time PCR in Tehran, Iran |
(Eng)
|
|
Raghibi M., Raghibi M., Morovvati A., Shakib P., Aflatoonian R., Dirbaiyan A.
|
| 卷 19, 编号 4 (2024) |
Formulation and Optimization of Solid Lipid Nanoparticle-based Gel for Dermal Delivery of Linezolid using Taguchi Design |
(Eng)
|
|
Chauhan I., Singh L.
|
| 卷 19, 编号 3 (2024) |
Green Chemistry and In silico Techniques for Synthesis of Novel Pyranopyrazole and Pyrazolo-pyrano-pyrimidine Derivatives as Promising Antifungal Agents |
(Eng)
|
|
Asgaonkar K., Chitre T., Patil S., Shevate K., Sagar A., Ghate D., Shah P.
|
| 卷 19, 编号 2 (2024) |
Investigation of Antifungal Action of Fractions C17H31NO15 Isolated from Artemisia herba-alba extract versus Isolated Aspergillus niger from Zee maize |
(Eng)
|
|
Amin B., Ayyat N., Mohamed El-Sharkawy R., Hafez A.
|
| 卷 19, 编号 2 (2024) |
Investigation of Anti-inflammatory, Antipyretic and Analgesic Activities of Citrullus colocynthis in Albino Rats through in vivo and Pharmacoinformatics Studies |
(Eng)
|
|
Hassan M., Zahra N., Shafi A., Shahzadi S., Moustafa A., Kloczkowski A.
|
| 卷 19, 编号 4 (2024) |
Investigation of EpsA, OmpA, and Bap Genes among MDR and XDR Acinetobacter baumannii Isolates in Khorramabad, Iran |
(Eng)
|
|
Poladi I., Shakib P., Halimi S., Delfani S., Zadeh F., Rezaei F.
|
| 卷 19, 编号 1 (2024) |
Meet the Editorial Board Member |
(Eng)
|
|
El Solh A.
|
| 卷 19, 编号 2 (2024) |
Meet the Section Editor |
(Eng)
|
|
Baptista M.
|
| 卷 19, 编号 2 (2024) |
Outpatient Intravenous Remdesivir to Prevent Progression to Severe COVID-19: An Observational Study from a Greek Hospital |
(Eng)
|
|
Kintrilis N., Galinos I.
|
| 卷 19, 编号 1 (2024) |
Preface |
(Eng)
|
|
Dai T.
|
| 卷 19, 编号 4 (2024) |
Recent Advances in Therapeutic Approaches Against Ebola Virus Infection |
(Eng)
|
|
Soni M., Tulsian K., Barot P., Vyas V.
|
| 卷 19, 编号 3 (2024) |
Study of Antimicrobial Resistance (AMR) in Shigella spp. in India |
(Eng)
|
|
Vaja M., Chokshi H., Jansari J., Dixit O., Savaliya S., Patel D., Patel F.
|
| 卷 19, 编号 3 (2024) |
Synthesis of Ursolic Acid-based Hybrids: In Vitro Antibacterial, Cytotoxicity Studies, In Silico Physicochemical and Pharmacokinetic Properties |
(Eng)
|
|
Khwaza V., Oselusi S., Morifi E., Nwamadi M., Hlope K., Ndinteh D., Matsebatlela T., Oyedeji O., Aderibigbe B.
|
| 卷 19, 编号 2 (2024) |
The Effect of COVID Convalescent Plasma on Hospital Stay: A Retrospective Observational Study from a Tertiary Care Hospital in North India |
(Eng)
|
|
Pandey P., Ranjan S., Setya D., Kumari S., Mandal S.
|
| 卷 19, 编号 3 (2024) |
The Efficacy of Colchicine as an Adjunct Therapy in Non-hospitalized COVID-19 Patients: A Randomized Placebo-Controlled Trial |
(Eng)
|
|
Hejazi S., Jahani Z., Elyasi S., Salarbashi D., Kabiri M.
|
| 卷 19, 编号 2 (2024) |
The Extent of Delay in Diagnosis, Treatment and their Associated Factors among Tuberculosis Patients Attending Government Hospitals of Rishikesh, Uttarakhand: A Cross-Sectional Study |
(Eng)
|
|
Supehia S., Singh M., Bahurupi Y., Aggarwal P., Chandra R., Sharma N.
|
| 卷 19, 编号 2 (2024) |
The Patent Landscape of mTOR and PTEN Targets |
(Eng)
|
|
Zhang H., Li Y.
|
| 1 - 30 的 30 信息 |
|
